Home » Industry News » Proveris SprayVIEW® Measurement System used in Development of First Generic Unit Dose Nasal Spray Approved by FDA
Proveris SprayVIEW® Measurement System used in Development of First Generic Unit Dose Nasal Spray Approved by FDA
Marlborough, MA, April 19, 2016 – Proveris Scientific Corporation announced today that the Company’s SprayVIEW® measurement system was used by Summit Biosciences during development of the first generic unit dose nasal spray product approved by the FDA.
Approval of the abbreviated new drug application (ANDA) for Sumatriptan nasal spray USP, 5 mg and 20 mg was received by Lannett Company, Inc. from the U.S. Food and Drug Administration (FDA). Summit Biosciences developed the product and will manufacture commercial supplies for distribution by Lannett.
"Proveris Scientific Corporation provides expert support for nasal developers. They are fast, reliable and are professionals at installing of their equipment and supports in demanding challenges."
Dr. Peter Svete, Head of Physical Analytics, Lek Pharmaceuticals d.d.
"Proveris provides insightful and thorough test services. We would recommend working with Proveris. Proveris has great expertise in spray analysis."
Elaine Schutte, Chief Development Officer, ProFibrix
"I want to express my sincere gratitude towards Proveris and the service team for being there to make sure our study goes well. The study just completed few minutes ago and thankfully everything went well.......while we conducted SAC study. It was a great display of professionalism by Proveris."
"As customary, Proveris's service team provided excellent service and was able to answer my questions."
"Thank you for the thorough training on our new equipment. I wish more companies would implement your hands on approach when it comes to training. Thanks again."
“We really appreciate the creativity and work conducted at Proveris for their Test Services (Proveris by Design®). Their knowledge, experience, and insight with OINDP’s was very helpful. Thanks to the Proveris team, we have a wonderful solution that we can use for commercial products!”
Mic Iwashima, NDS Division, Shin Nippon Biomedical Laboratories, Ltd